Inactivated dengue virus vaccine with aluminium-free adjuvant

Details for Australian Patent Application No. 2010215595 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Baras, Benoit; Gheysen, Dirk; Knott, Isabelle Solange Lucie; Prieels, JeanPaul; Toussaint, Jean-Francois

Agent Davies Collison Cave

Pub. Number AU-A-2010215595

PCT Pub. Number WO2010/094663

Priority 61/153,060 17.02.09 US

Filing date 16 February 2010

Wipo publication date 26 August 2010

International Classifications

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/094663 Priority application(s): WO2010/094663

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215597-Compositions and methods for degrading lignocellulosic biomass

2010215591-Amine or amino alcohols as GlyT1 inhibitors